Xvivo Perfusion AB (FRA:3XV)
€ 39.75 -0.3 (-0.75%) Market Cap: 1.24 Bil Enterprise Value: 1.20 Bil PE Ratio: 70.74 PB Ratio: 7.04 GF Score: 85/100

Xvivo Perfusion AB Capital Markets Day Transcript

Sep 23, 2021 / 11:00AM GMT
Release Date Price: €40.8
Lars Frick

Good afternoon, and welcome to Gothenburg, for those who braved the elements and came here inside. And a big welcome to those of you who are listening in on the live broadcast. This is a very special day. It's the inaugural Capital Markets Day for XVIVO. Today, you will learn about operations, gain clinical insights and also learn about the strategic road map for XVIVO during the coming years.

My name is Lars Frick. I'm a journalist at Tidningen Börsveckan, and I will be a moderator here today. The Capital Markets Day will be hosted by management from XVIVO as well as clinical partners who will participate. It will be broadcast live. And for those of us who join on the Internet, you can ask questions, too. Just use the Q&A field, which is below the screen on your browser, and then I will forward this during the Q&A sessions.

So on a practical note, today is divided into 3 main areas. First of all, it's the economic side of operations with markets trends, strategy and health economics. After that, there will be a Q&A session. And for those of you who are present here,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot